Preliminary scientific tests suggest conolidine might inhibit unique ion channels, lowering neuronal excitability and limiting ache alerts. This mechanism is especially suitable in neuropathic suffering, where abnormal signaling will cause persistent discomfort. Moreover, conolidine seems to affect G protein-coupled receptor (GPCR) pathways integra